Scientists Edge Closer To Elusive Lab Test For 'Chronic Fatigue Syndrome'

Stanford University scientists have found an array of proteins in the blood whose levels correlate closely with the severity of symptoms of the mysterious illness that's increasingly known as ME/CFS.
In addition to profound exhaustion that isn't relieved with sleep, the illness now called ME/CFS includes flu-like symptoms, muscle pain, "brain fog" and various other physical symptoms, all of which typically worsen with even minor exertion. Source: Malte Mueller/Getty Images

Imagine feeling horribly sick, day after day, yet doctors repeatedly tell you they can't find anything wrong. That typically happens to people with the mysterious illness commonly known as "chronic fatigue syndrome." Research findings from Stanford University released Monday could point the way to a long-sought diagnostic laboratory test for the condition, and possibly a first-ever treatment.

Believed to affect at least a million people in the U.S., the condition is now increasingly termed myalgic encephalomyelitis/chronic fatigue syndrome, or ME/CFS for short.

Many patients see the name "chronic proposed the name "systemic exertion intolerance disease," but it hasn't really stuck.)

You're reading a preview, sign up to read more.

More from NPR

NPR2 min read
We Did It For The LOLs: 100 Favorite Funny Books
We thought you might need a laugh right about now, so this year's summer reader poll celebrates all the books (and one short story, and a few uncategorizable gems) that make you laugh out loud.
NPR2 min read
Shannon Bond Joins NPR's Business Desk
In a note to newsroom staff, Chief Business Editor Pallavi Gogoi announced the following staffing update: I'm delighted to announce that Shannon Bond is joining NPR as Technology Correspondent, based in Silicon Valley. Shannon currently covers techno
NPR3 min readPolitics
New California Law Says Police Should Kill Only When 'Necessary'
The legislation is a response to police killings of unarmed black men such as Stephon Clark. But critics say it doesn't go far enough.